Akari Therapeutics, Plc
AKTX
$1.12
-$0.03-2.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.58M | 2.60M | 2.25M | 4.18M | 1.31M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 627.00K | 92.00K | 396.00K | 805.00K | 1.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 140.00K | 261.00K | 92.00K | 94.00K | 232.00K |
| Total Current Assets | 3.35M | 2.95M | 2.73M | 5.08M | 2.77M |
|
|
|||||
| Total Current Assets | 3.35M | 2.95M | 2.73M | 5.08M | 2.77M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 8.43M | 8.43M | -- | -- | -- |
| Goodwill | 8.43M | 8.43M | -- | -- | -- |
| Total Other Intangibles | 39.18M | 39.18M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 50.96M | 50.56M | 2.73M | 5.08M | 2.77M |
|
|
|||||
| Total Accounts Payable | 13.07M | 12.41M | 4.78M | 4.69M | 3.21M |
| Total Accrued Expenses | 3.49M | 3.14M | 2.61M | 1.69M | 1.53M |
| Short-term Debt | 1.85M | 3.26M | 1.00M | 1.00M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.50M | 1.11M | 1.04M | 1.41M | 1.59M |
| Total Other Current Liabilities | 2.50M | 1.11M | 1.04M | 1.41M | 1.59M |
| Total Current Liabilities | 20.91M | 19.91M | 9.43M | 8.78M | 6.33M |
|
|
|||||
| Total Current Liabilities | 20.91M | 19.91M | 9.43M | 8.78M | 6.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.85M | 3.26M | 1.00M | 1.00M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.31M | 8.42M | -- | -- | -- |
| Total Liabilities | 29.21M | 28.33M | 9.43M | 8.78M | 6.33M |
|
|
|||||
| Common Stock & APIC | 221.28M | 218.03M | 185.52M | 185.44M | 178.04M |
| Retained Earnings | -250.96M | -247.25M | -243.48M | -240.59M | -233.03M |
| Treasury Stock & Other | 51.42M | 51.46M | 51.27M | 51.45M | 51.43M |
| Total Common Equity | 21.75M | 22.23M | -6.69M | -3.70M | -3.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.75M | 22.23M | -6.69M | -3.70M | -3.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21.75M | 22.23M | -6.69M | -3.70M | -3.55M |
|
|
|||||